Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

2010112 citationsJournal Articlebronze Open Access

Authors

Jörg Janne Vehreschild · University of Cologne

Maria J. G. T. Rüping · University of Cologne

Hilmar Wisplinghoff · University of Cologne

Fedja Farowski · University of Cologne

Angela Steinbach · University of Cologne

Robert B. Sims · University of Cologne

A. Stollorz ·

Abstract

After introduction of posaconazole prophylaxis for patients with AML, the number of febrile days, the incidence rate of IFDs and aspergillosis and the duration of hospitalization decreased significantly.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Neutropenia and Cancer Infections

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Antimicrobial Chemotherapy

Volume 65, Issue 7, pp. 1466-1471

DOI: 10.1093/jac/dkq121

Field-Weighted Citation Impact: 5.67